Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
Related ArticlesRetina Foundation to Conduct First Optogenetics Gene Therapy Clinical Trial National Eye Institute Awards $949,804 for a 5-Year Study of RP Gene Causing Blindness Found in Texas Hispanic Families Fogg Charitable Trust Awards $50,000 Grant to the Retina Foundation Introducing the Vision and Neurodevelopment Laboratory